Detalles de la búsqueda
1.
Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection.
Nat Immunol
; 21(10): 1302, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32855556
2.
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection.
Nat Immunol
; 21(10): 1293-1301, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32807944
3.
Activation-based repertoire analysis for T cell clonal dynamics in hybrid COVID-19 immunity.
Nat Immunol
; 25(1): 7-8, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38168958
4.
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong.
Respirology
; 27(4): 301-310, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34820940
5.
Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children.
Nat Commun
; 15(1): 3210, 2024 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615070
6.
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents.
World J Pediatr
; 2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38085470
7.
Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents.
Front Immunol
; 14: 1106837, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36949953
8.
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial.
Lancet Microbe
; 4(9): e670-e682, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37549680
9.
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents.
Signal Transduct Target Ther
; 7(1): 397, 2022 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36517469
10.
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents.
Nat Commun
; 13(1): 3700, 2022 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35764637
11.
Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread.
Viruses
; 13(9)2021 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34578360
12.
T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants.
Front Med (Lausanne)
; 8: 793102, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35004764
13.
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.
Nat Commun
; 12(1): 4678, 2021 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34326343
14.
Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults.
NPJ Vaccines
; 6(1): 25, 2021 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33594050
15.
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.
medRxiv
; 2021 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33564773
16.
Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults.
Clin Transl Immunology
; 9(2): e1107, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32025302
17.
Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents.
Nat Commun
; 13(1): 4798, 2022 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970832
Resultados
1 -
17
de 17
1
Próxima >
>>